The development of human gonadotropins and their use in infertility: a personalized history

Editorial

Like Comment
Related Content

VOLUME 1, ISSUE 2, P106-112, NOVEMBER 01, 2020

Author:

Robert W. Rebar, M.D. 

Abstract:

The story of the gonadotropins begins early in the twentieth century, when several clinicians reported that destructive lesions of the anterior pituitary gland resulted in several untoward effects, including gonadal atrophy. However, the critical role of the anterior pituitary gland in stimulating and maintaining gonadal function was established by means of a series of classic experiments in animals. The first experimental evidence was provided in 1910 by Harvey Cushing’s group, who demonstrated the effects of hypophysectomy in dogs (1). In 1921, Evans and Long reported that the intraperitoneal injection of anterior pituitary extracts could alter the estrus cycle and stimulate growth in rats (2). In 1927, Smith and Engle noted that anterior pituitary extracts could induce precocious puberty in immature rats and mice (3). Smith also reported that young hypophysectomized rats replaced with anterior pituitary extracts did not undergo gonadal atrophy or atrophy of the thyroid and adrenal gland (4).

Read the full text here. 

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.